Lilly Immunodermatology Award to Dr. Daniela Impellizzieri

7448a0265a74f64f42ba86d2e612940d.jpg

Institute of Oncology Research

10 November 2022

Since 2017, the SGDV (Swiss Society of Dermatology and Venerology) has awarded an annual prize provided by Eli Lilly (Suisse) S.A. to promote research in the field of immunodermatology. An award of CHF 10'000 is allocated for the research activity of young scientists up to 40 years old. Applications are evaluated by a scientific committee and presented at the annual SGDV meeting. The 2022 prize was awarded to Dr. Daniela Impellizzieri, PhD, for her work on the role of neutrophils in type 2 immunity, commonly observed in tissues during allergic inflammation or parasitic infections.

She is currently working as Researcher in the Experimental Therapies group directed by Prof. Carlo Catapano at the Institute of Oncology Research (IOR, affiliated to USI and member of Bios+) in Bellinzona, on projects aimed at the identification of tumor-associated antigens, in particular prostate cancer, for the design of selective therapies with drug-conjugated antibodies.

Dr. Impellizzieri received her PhD in immunology in 2019 from UniversitätsSpital Zurich, producing ten scientific publications with high impact factor, including three first authorship papers.

Faculties

Events
29
May
2024
29.
05.
2024
31
May
2024
31.
05.
2024
03
June
2024
03.
06.
2024
04
June
2024
04.
06.
2024

L'interdisciplinarietà come chiave di lettura per l'inclusività

Faculty of Communication, Culture and Society